Literature DB >> 26211712

The role of DNA damage and repair in atherosclerosis: A review.

Nikunj R Shah1, Michael Mahmoudi2.   

Abstract

The global burden of cardiovascular disease is increasing despite therapeutic advances in medication and interventional technologies. Accumulated deoxyribonucleic acid (DNA) damage and subsequent repair pathways are now increasingly recognised as a causal factor in the initiation and progression of atherosclerosis. These molecular alterations have been shown to occur within affected vasculature, plaque microenvironment as well as in circulating cells. The DNA damage response (DDR) pathway is reliant on post-translational modification of sensing proteins which activate a signalling cascade to repair, if possible, DNA damaged sites in response to various environmental and physiological insults. This review summarises the current evidence for DNA damage in atherosclerosis, the key steps involved in the DDR pathway, DNA repair and their subsequent effects on atherosclerotic plaques, as well as the therapeutic options in managing DNA damage-induced atherosclerosis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Deoxyribonucleic acid; Repair enzymes

Mesh:

Year:  2015        PMID: 26211712     DOI: 10.1016/j.yjmcc.2015.07.005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  19 in total

1.  Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death.

Authors:  Xuwei Hou; Patricia Snarski; Yusuke Higashi; Tadashi Yoshida; Alexander Jurkevich; Patrick Delafontaine; Sergiy Sukhanov
Journal:  FASEB J       Date:  2017-04-12       Impact factor: 5.191

Review 2.  Genome instability in Alzheimer disease.

Authors:  Yujun Hou; Hyundong Song; Deborah L Croteau; Mansour Akbari; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2016-04-20       Impact factor: 5.432

Review 3.  Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Carolyn Gotay; Andrew Ignaszewski; Andrew D Krahn; Margot K Davis; Christopher Franco; Arya Mani
Journal:  Atherosclerosis       Date:  2017-06-02       Impact factor: 5.162

4.  The size-dependent genotoxicity and oxidative stress of silica nanoparticles on endothelial cells.

Authors:  Furong Zhou; Fen Liao; Lingying Chen; Yuanfeng Liu; Wuxiang Wang; Shaolong Feng
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-20       Impact factor: 4.223

5.  Genetic variants associated with earlier age at menopause increase the risk of cardiovascular events in women.

Authors:  Chloé Sarnowski; Maryam Kavousi; Steve Isaacs; Ellen W Demerath; Linda Broer; Taulant Muka; Oscar H Franco; Mohammad Arfan Ikram; André Uitterlinden; Nora Franceschini; Kathryn L Lunetta; Joanne M Murabito
Journal:  Menopause       Date:  2018-04       Impact factor: 2.953

6.  INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.

Authors:  Ping Wang; Dan Ma; Jishi Wang; Qin Fang; Rui Gao; Weibing Wu; Lu Cao; Xiuying Hu; Jiangyuan Zhao; Yan Li
Journal:  Tumour Biol       Date:  2016-06-24

7.  Oxidative Stress, DNA Damage and DNA Repair in Female Patients with Diabetes Mellitus Type 2.

Authors:  Annemarie Grindel; Bianca Guggenberger; Lukas Eichberger; Christina Pöppelmeyer; Michaela Gschaider; Anela Tosevska; George Mare; David Briskey; Helmut Brath; Karl-Heinz Wagner
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

8.  Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.

Authors:  Wen-Qi Ma; Xi-Qiong Han; Xin Wang; Ying Wang; Yi Zhu; Nai-Feng Liu
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

9.  Puzzles in modern biology. IV. Neurodegeneration, localized origin and widespread decay.

Authors:  Steven A Frank
Journal:  F1000Res       Date:  2016-10-19

10.  Therapeutic effects of fibroblast growth factor‑21 against atherosclerosis via the NF‑κB pathway.

Authors:  Yiming Zhang; Zhao Liu; Min Zhou; Changjian Liu
Journal:  Mol Med Rep       Date:  2017-11-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.